In 1993, germline missense mutation was found in RET protooncogene on chromosome 10q11.2, that is, which is a point mutation in the methionine residue in exon 16 and is responsible for about 95% of MEN 2B cases [4]. This evidence concerns the gene RET and multiple endocrine neoplasia type 2B.